Sülforafan ve Kanser

Soundararajan P, Kim JS. Anti-carcinogenic glucosinolates in cruciferous vegetables and their antagonistic effects on prevention of cancers. Molecules. 2018;23(11).

Huang A, Yang XR, Chung WY, et al. Targeted therapy for hepatocellular carcinoma. Signal Transduction and Targeted Therapy. 2020;5(1). doi:10.1038/s41392-020-00264-x

Elkashty OA, Tran SD. Sulforaphane as a Promising Natural Molecule for Cancer Prevention and Treatment. Current Medical Science. 2021;41(2):250–69.

Wu G, Yan Y, Zhou Y, et al. Sulforaphane: Expected to Become a Novel Antitumor Compound. Oncology Research. 2020;28(4):439–46.

Mangla B, Javed S, Sultan MH, et al. Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials. Phytotherapy Research. 2021;(March):1–19.

Vanduchova A, Anzenbacher P, Anzenbacherova E. Isothiocyanate from Broccoli, Sulforaphane, and Its Properties. JOURNAL OF MEDICINAL FOOD. 2019;22(2):121–126. doi:10.1089/jmf.2018.0024

Li F, Hullar MAJ, Beresford SAA, et al. Variation of glucoraphanin metabolism in vivo and ex vivo by human gut bacteria. The British journal of nutrition. 2011/02/23. 2011 Aug;106(3):408–16. doi:10.1017/S0007114511000274

Kaiser AE, Baniasadi M, Giansiracusa D, et al. Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential. Cancers. 2021;13:4796. doi:10.3390/cancers13194796

Zhang Y, Tang L. Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacologica Sinica. 2007 Sep;28(9):1343–54.

Zhang YS, Kolm RH, Mannervik B, et al. Reversible Conjugation of Isothiocyanates with Glutathione Catalyzed by Human Glutathione Transferases. Biochemical and Biophysical Research Communications. 1995 Jan 17;206(2):748–55.

Zhang Y. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis. 2000 Jun 1;21(6):1175–82. doi:10.1093/carcin/21.5.175

Callaway EC, Zhang Y, Chew W, et al. Cellular accumulation of dietary anticarcinogenic isothiocyanates is followed by transporter-mediated export as dithiocarbamates. Cancer Letters. 2004 Feb 10;204(1):23–31.

Hu R, Khor TO, Shen G, et al. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis. 2006 Oct 1;27(10):2038–46. doi:10.1093/carcin/bgl049

Zhang Y, Wade KL, Prestera T, et al. Quantitative Determination of Isothiocyanates, Dithiocarbamates, Carbon Disulfide, and Related Thiocarbonyl Compounds by Cyclocondensation with 1,2-Benzenedithiol. Analytical Biochemistry. 1996;239(2):160–7. doi:10.1006/abio.1996.0311

Cornblatt BS, Ye L, Dinkova-Kostova AT, et al. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis. 2007 Jul 1;28(7):1485–90. doi:10.1093/carcin/bgm049

Ye L, Dinkova-Kostova AT, Wade KL, et al. Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clinica Chimica Acta. 2002;316(1):43–53. doi: 10.1016/S0009-8981(01)00727-6

Atwell LL, Hsu A, Wong CP, et al. Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract. Molecular Nutrition & Food Research. 2015 Mar 1;59(3):424–33. doi:10.1002/mnfr.201400674

Myzak MC, Tong P, Dashwood WM, et al. Sulforaphane Retards the Growth of Human PC-3 Xenografts and Inhibits HDAC Activity in Human Subjects. Experimental biology and medicine (Maywood, NJ). 2007 Feb;232(2):227.

Socała K, Nieoczym D, Kowalczuk-Vasilev E, et al. Increased seizure susceptibility and other toxicity symptoms following acute sulforaphane treatment in mice. Toxicology and Applied Pharmacology. 2017;326:43–53. doi: 10.1016/j.taap.2017.04.010

Alumkal JJ, Slottke R, Schwartzman J, et al. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. doi:10.1007/s10637-014-0189-z

Shapiro TA, Fahey JW, Dinkova-Kostova AT, et al. Safety, Tolerance, and Metabolism of Broccoli Sprout Glucosinolates and Isothiocyanates: A Clinical Phase I Study. Nutrition and Cancer. 2006 Jul 1;55(1):53–62. doi:10.1207/s15327914nc5501_7

Kerr C, Adhikary G, Grun D, et al. Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma. Molecular Carcinogenesis. 2018 Jan 1;57(1):3–11. doi:10.1002/MC.22714

Yagishita Y, Fahey JW, Dinkova-Kostova AT, et al. Broccoli or sulforaphane: Is it the source or dose that matters? Molecules. 2019. 24 doi:10.3390/molecules24193593

Jeffery EH, Keck AS. Translating knowledge generated by epidemiological and in vitro studies into dietary cancer prevention. Molecular Nutrition & Food Research. 2008; 1;52(S1):S7–17. doi:10.1002/mnfr.200700226

Houghton CA, Fassett RG, Coombes JS. Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician’s Expectation Be Matched by the Reality? Abdel Moneim A, editor. Oxidative Medicine and Cellular Longevity. 2016;2016:7857186. doi:10.1155/2016/7857186

Clarke MF. Clinical and Therapeutic Implications of Cancer Stem Cells. New England Journal of Medicine. 2019;380(23):2237–45.

Aumeeruddy MZ, Mahomoodally MF. Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone. Cancer. 2019 May 15;125(10):1600–11. doi:10.1002/cncr.32022

Russo M, Spagnuolo C, Russo GL, et al. Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment. 2017 24;58(8):1391–405. doi:10.1080/10408398.2016.1259983

Su X, Jiang X, Meng L, et al. Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2018;2018. doi:10.1155/2018/5438179

Lewinska A, Adamczyk-Grochala J, Deregowska A, et al. Sulforaphane-induced cell cycle arrest and senescence are accompanied by DNA hypomethylation and changes in microRNA profile in breast cancer cells. Theranostics. 2017;7(14):3461–77.

Burnett JP, Lim G, Li Y, et al. Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells. Cancer Letters. 2017;394:52–64. doi:10.1016/j.canlet.2017.02.023

Sharma C, Sadrieh L, Priyani A, et al. Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiology. 2011;35(3):272–8. doi: 10.1016/j.canep.2010.09.008

Gong TT, Liu XD, Zhan ZP, et al. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells. Experimental Cell Research. 2020;393(2):112061. doi:10.1016/j.yexcr.2020.112061

Liu CM, Peng CY, Liao YW, et al. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction. Journal of the Formosan Medical Association. 2017;116(1):41–8. doi:10.1016/j.jfma.2016.01.004

Moon DO, Kang SH, Kim KC, et al. Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway. Cancer Letters. 2010;295(2):260–6. doi: 10.1016/j.canlet.2010.03.009

Wu J, Han J, Hou B, et al. Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway. Oncol Rep. 2016;35(5):2977–83. doi:10.3892/or.2016.4638

Anwar-Mohamed A, El-Kadi AOS. Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human HepG2 cells. Cancer Letters. 2009;275(1):93–101. doi:10.1016/j.canlet.2008.10.003

Pham NA, Jacobberger JW, Schimmer AD, et al. The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Molecular cancer therapeutics. 2004 Oct;3(10):1239–48. doi:10.1158/1535-7163.1239.3.10

Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial–mesenchymal transition in cancer development and its clinical significance. Cancer Science. 2010 Feb 1;101(2):293–9. doi:10.1111/j.1349-7006.2009.01419.x

Shan Y, Zhang L, Bao Y, et al. Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. Journal of Nutritional Biochemistry. 2013;24(6):1062–9. doi:10.1016/j.jnutbio.2012.08.004

Li Q, Yao Y, Eades G, et al. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene. 2014;33(20):2589–600.

Li X, Zhao Z, Li M, et al. Sulforaphane promotes apoptosis, and inhibits proliferation and self-renewal of nasopharyngeal cancer cells by targeting STAT signal through miRNA-124-3p. Biomedicine and Pharmacotherapy. 2018;103(March):473–81. doi:10.1016/j.biopha.2018.03.121

Srivastava RK, Tang SN, Zhu W, et al. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells Rakesh. Frontiers in Bioscience. 2011;3(2):515–28.

Park SY, Kim GY, Bae SJ, et al. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncology Reports. 2007;18(1):181–7.

Li Y, Zhang T, Korkaya H, et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clinical Cancer Research. 2010;16(9):2580–90.

Porta C, Paglino C, Mosca A. Targeting PI3K/Akt/mTOR signaling in cancer. Frontiers in Oncology. 2014 Apr 14;4 APR:64.

Shen G, Khor TO, Hu R, et al. Chemoprevention of Familial Adenomatous Polyposis by Natural Dietary Compounds Sulforaphane and Dibenzoylmethane Alone and in Combination in ApcMin/+ Mouse. Cancer Research. 2007 17;67(20):9937–44. doi:10.1158/0008-5472.CAN-07-1112

Chaudhuri D, Orsulic S, Ashok BT. Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells. Molecular Cancer Therapeutics. 2007 Jan;6(1):334–45.

ClinicalTrials.gov. Available from: https://clinicaltrials.gov (Accessed 23rd January 2023).

ClinicalTrials.gov. Search of: sulforaphane - List Results - Available from: https://clinicaltrials.gov/ct2/results?cond=&term=sulforaphane&cntry=&state=&city=&dist= (Accessed 23rd January 2023).

Shiina A, Kanahara N, Sasaki T, et al. An open study of sulforaphane-rich broccoli sprout extract in patients with schizophrenia. Clinical Psychopharmacology and Neuroscience. 2015 Apr 1;13(1):62–7. doi:10.9758/CPN.2015.13.1.62

Noah TL, Zhang H, Zhou H, et al. Effect of broccoli sprouts on nasal response to live attenuated influenza virus in smokers: A randomized, double-blind study. PLoS ONE. 2014 Jun 9;9(6).

Kirkwood J. Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions - Full Text View. Available from:https://clinicaltrials.gov/ct2/show/NCT01568996?term=NCT01568996&draw=1&rank=1 (Accessed 23rd January 2023).